Articles by Jef Feeley

J&J’s Controversial Prison Testing Resurfaces in Baby Powder Lawsuits

More than 50 years ago, nearly a dozen men incarcerated outside of Philadelphia enrolled in an experiment funded by Johnson & Johnson, according to unsealed documents. Now, those studies have come back to haunt the world’s largest maker of health-care …

Purdue’s Sacklers Consider Adding $1 Billion More to Opioid Settlement

Members of the billionaire Sackler family that own Purdue Pharma LP are weighing whether to add $1 billion to the OxyContin-maker’s faltering opioid settlement bid in an effort to win over holdouts, according to people familiar with the offer. The …

Why Jury’s Opioid Verdict Against Pharmacy Chains May Not Survive Appeal

While a Cleveland jury concluded Walmart Inc., CVS Health Corp. and Walgreens Boots Alliance Inc. exacerbated Ohio’s opioid epidemic with lax oversight of prescription painkillers, the verdict may not survive on appeal, according to legal experts. The companies, which vowed …

Ohio Jury Finds Major Pharmacy Chains Fueled Opioid Crisis

A Cleveland jury concluded Walmart Inc., CVS Health Corp. and Walgreens Boots Alliance Inc. helped create a public-health crisis by failing to properly monitor opioid prescriptions, the drug industry’s latest loss in the expanding litigation over the painkillers. The federal-court …

How J&J Shaped Report on Talc’s Links to Cancer

Unsealed emails reveal the role baby-powder maker Johnson & Johnson played in a report that an industry group submitted to U.S. regulators deciding whether to keep warnings off talc-based products linked to cancer. The emails — unsealed in the state …

Judge Dismisses Chemours Shareholder Suit Over DuPont Spinoff Liabilities

A Delaware judge dismissed a suit by Chemours Co. shareholders alleging directors misled them about the company’s financial health and legal liabilities when it was spun off from a predecessor of DuPont de Nemours Inc. Chemours shareholders can’t show misleading …

Months Before Bankruptcy Move, J&J Offered $4B to Settle Talcum Claims

Months before putting one of its units into bankruptcy, Johnson & Johnson offered $4 billion to settle with victims of its talc-based powder — twice the amount it’s now proposing to pay through a forced resolution, according to people familiar …

Potentially ‘Massive’ Litigation Over Recalled Philips Sleep Apnea Devices Advances

Royal Philips NV will face more than 100 U.S. lawsuits gathered in a Pennsylvania court over its recall of more than 3 million devices used to treat sleep apnea that are linked to cancer concerns. Amsterdam-based Philips, maker of respiratory …

Drug Industry Faces First High-Stakes Opioid Jury Trial

Jurors on New York’s Long Island are set to determine whether a group of opioid makers and drug distributors created a public health crisis and should pay for it, in a bellwether trial for lawsuits filed by communities across the …

J&J Reports $263M Resolution of N.Y. Opioid Lawsuits Before Trial

Johnson & Johnson said it agreed to pay $263 million to resolve opioid lawsuits filed in New York, settling the cases on the eve of the first U.S. jury trial over claims the company mishandled the highly addictive painkillers. The …